Moderna, Inc. (BIT:1MRNA)

Italy flag Italy · Delayed Price · Currency is EUR
27.49
-0.74 (-2.60%)
At close: Jul 15, 2025, 5:30 PM CET
-2.60%
Market Cap10.78B
Revenue (ttm)2.94B
Net Income (ttm)-3.11B
Shares Outn/a
EPS (ttm)-8.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,407
Average Volume4,589
Open28.31
Previous Close28.23
Day's Range27.37 - 28.43
52-Week Range20.67 - 115.92
Betan/a
RSI56.02
Earnings DateJul 31, 2025

About Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Employees 5,800
Stock Exchange Borsa Italiana
Ticker Symbol 1MRNA
Full Company Profile

Financial Performance

In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.